The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE

The interleukin 21 pathway is critical for development of pathogenic antibodies in a chronic GVH model of SLE

Detalles Bibliográficos
Autores principales: Damphousse, C, Groves, C, Brown, T, Lowe, L, Nickerson-Nutter, C, Collins, M, Jr, O, Young, D
Formato: Conference item
Publicado: 2006

Ejemplares similares